Anti-MAP3K2 (K260me3) Antibody (SAA2423) from ProteoGenix; catalogue ARO-A22869; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The MAP3K2 (mitogen-activated protein kinase kinase kinase 2) signaling pathway is a crucial regulator of cell growth, differentiation, and survival. Dysregulation of this pathway has been linked to various diseases, including cancer and inflammatory disorders. To better understand the role of MAP3K2 in these conditions, researchers rely on specific tools, such as antibodies, to study its function and signaling mechanisms. The Anti-MAP3K2 (K260me3) Antibody (SAA2423) is a highly specific and reliable tool for studying MAP3K2 and its downstream targets.
The Anti-MAP3K2 (K260me3) Antibody (SAA2423) is a polyclonal antibody that specifically targets the K260me3 modification of MAP3K2. This modification plays a critical role in regulating the activity of MAP3K2 and its downstream signaling pathways. By targeting this specific modification, the antibody allows for precise and accurate detection of MAP3K2 and its activity in cells and tissues.
The Anti-MAP3K2 (K260me3) Antibody (SAA2423) is a valuable tool for a wide range of applications in both basic and clinical research. It can be used for immunoblotting, immunoprecipitation, and immunofluorescence assays to detect and quantify MAP3K2 levels and activity. Additionally, the antibody can be used in studies investigating the role of MAP3K2 in various diseases, including cancer and inflammatory disorders.
The Anti-MAP3K2 (K260me3) Antibody (SAA2423) has been successfully used in numerous studies to elucidate the role of MAP3K2 in different cellular processes and diseases. For example, it has been used to study the role of MAP3K2 in regulating cell proliferation and survival in cancer cells. It has also been used to investigate the involvement of MAP3K2 in inflammatory signaling pathways, providing valuable insights into the development of inflammatory diseases.
In conclusion, the Anti-MAP3K2 (K260me3) Antibody (SAA2423) is a highly specific and reliable tool for studying MAP3K2 and its signaling pathways. Its ability to target the K260me3 modification of MAP3K2 makes it a valuable asset for researchers interested in understanding the role of this protein in various diseases. With its wide range of applications and proven effectiveness in experimental studies, this antibody is an essential tool for any researcher studying MAP3K2 function and signaling. Order now and unlock the potential of MAP3K2 research.
ProteoGenix catalogue number ARO-A22869. For research use only.
Target: Mitogen-activated protein kinase kinase kinase 21, EC:2.7.11.25, Mitogen-activated protein kinase kinase kinase MLK4, Mixed lineage kinase 4, MAP3K21, KIAA1804, MLK4; Clonality: Monoclonal Antibody; Applications: SPR, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | SPR |
|---|---|---|---|---|---|---|---|---|---|
| Mitogen-activated protein kinase kinase kinase 21, EC |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
